Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

8 Aug 2011 11:45

RNS Number : 9283L
Oryx International Growth Fund Ld
08 August 2011
 

ORYX INTERNATIONAL GROWTH FUND LIMITED

 8 August 2011

 INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 30 JUNE 2011

Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

This interim management statement relates to the period from 1 April 2011 to 30 June 2011, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 Manager's Review

Markets drifted for the majority of the period under review with the FTSE Small Cap TR Index up 0.7% and the FTSE All-Share TR Index (£) down 0.9%. It is pleasing to report that against this backdrop the net asset value rose by 8.8% to 296p per share. The increase in the portfolio was broadly based, although there was no movement in the value of the unquoted portfolio. Whilst current market conditions are difficult the manager believes there is inherent value in the portfolio which will be realised in the next quarter.

Material TransactionsSince 1 April 2011 the Company has purchased for cancellation the following shares:

15 April 2011 a total of 250,000 ordinary shares at a gross price of £2.30 per share.27 May 2011 a total of 170,000 ordinary shares at a gross price of £2.30 per share.

Material EventsThere were no material events during the quarter ended 30 June 2011.

Report and AccountsOn 30 June 2011, the Company posted its Annual Report for the year ended 31 March 2011 to Shareholders together with a circular containing the Notice convening the Company's AGM at 11am on 12 August 2011 and details of a proposed waiver of the Rule 9 provisions of the City Code on Takeovers and Mergers.

 

Financial Highlights

 

 

30 June 2011

31 March 2011

31 December 2010

30 June 2010

 

 

 

 

 

NAV

£2.96

£2.72

£2.81

£2.35

 

 

 

 

 

US Dollar / Sterling Exchange Rate

 1.6055

 1.6029

 1.5657

 1.4961

 

 

 

 

 

 

 

Twenty Largest Equity Investments at 30 June 2011

 

% Net Assets

RPC Group Plc

7.60

CVS Group Plc

7.01

Guinness Peat Group Plc

6.72

BBA Aviation Plc

6.38

Gleeson (M.J.) Group Plc

6.11

Augean

5.34

Orthoproducts Ltd

4.68

Quarto Group Inc

4.54

GTL Resources Plc

4.19

Bavaria Industriekapital AG

4.02

Idox Plc

3.92

Sinclair Pharma Plc

3.51

Innovation Group Plc

3.39

Catalyst Media Group Plc

3.38

Redhall Group Plc

3.21

Journey Group Plc

2.99

Nastor Inv Ltd Zero Redeem Prefer Shares

2.38

Bionostics Holdings Ltd

2.19

Green Co2 Plc

2.13

Celsis AG

1.64

85.33

 

The financial information for the quarter ended 30 June 2011 contained within this Interim Management Statement has not been audited.

By order of the Board

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf ofOryx International Growth Fund Limitedas Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUGUUPRUPGGUR
Date   Source Headline
12th Nov 20204:34 pmRNSHolding(s) in Company
5th Nov 20204:35 pmRNSTR-1
26th Oct 20204:50 pmRNSHoldings in Company
19th Oct 20209:12 amRNSHolding(s) in Company
14th Oct 20204:35 pmRNSNet Asset Value(s)
14th Oct 20208:00 amRNSHolding(s) in Company
1st Oct 202012:29 pmRNSTotal Voting Rights
25th Sep 202012:49 pmRNSNotification of Major Shareholdings
23rd Sep 202011:09 amRNSNet Asset Value(s)
9th Sep 20202:03 pmRNSTransaction in Own Shares
8th Sep 20203:06 pmRNSHolding(s) in Company
1st Sep 20203:48 pmRNSHolding(s) in Company
28th Aug 202011:25 amRNSResult of AGM
24th Aug 20203:11 pmRNSNet Asset Value(s)
7th Aug 20208:56 amRNSHolding(s) in Company
4th Aug 20201:06 pmRNSHolding(s) in Company
31st Jul 20202:58 pmRNSNotice of AGM
23rd Jul 20204:27 pmRNSHolding(s) in Company
23rd Jul 20202:55 pmRNSAnnual Financial Report
22nd Jul 202010:23 amRNSNet Asset Value(s)
20th Jul 20202:08 pmRNSHolding(s) in Company
17th Jul 202012:19 pmRNSHolding(s) in Company
2nd Jul 202011:07 amRNSHolding(s) in Company
30th Jun 20207:00 amRNSHolding(s) in Company
22nd Jun 20203:54 pmRNSNet Asset Value(s)
29th May 20208:31 amRNSHolding(s) in Company
26th May 202012:39 pmRNSNet Asset Value(s)
22nd May 202011:10 amRNSHolding(s) in Company
4th May 20201:46 pmRNSNet Asset Value(s)
1st May 20203:19 pmRNSHolding(s) in Company
20th Apr 20201:24 pmRNSHolding(s) in Company
20th Apr 20201:23 pmRNSHolding(s) in Company
14th Apr 20203:06 pmRNSHolding(s) in Company
6th Apr 20208:34 amRNSHolding(s) in Company
18th Mar 20204:22 pmRNSNet Asset Value(s)
10th Mar 20202:14 pmRNSHolding(s) in Company
6th Mar 20203:57 pmRNSHolding(s) in Company
26th Feb 20203:03 pmRNSHolding(s) in Company
24th Feb 20204:31 pmRNSNet Asset Value(s)
18th Feb 20203:19 pmRNSHoldings in Company
11th Feb 202012:31 pmRNSHolding(s) in Company
22nd Jan 20205:08 pmRNSNet Asset Value(s)
17th Jan 20204:05 pmRNSHolding(s) in Company
17th Jan 20209:22 amRNSHolding(s) in Company
10th Jan 20205:39 pmRNSHolding(s) in Company
8th Jan 20201:35 pmRNSHolding(s) in Company
8th Jan 20201:34 pmRNSHolding(s) in Company
8th Jan 202012:13 pmRNSHolding(s) in Company
20th Dec 20195:01 pmRNSNet Asset Value(s)
18th Dec 20192:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.